Bill Commons

HI HB 108

died on adjournment

RELATING TO INTOXICATING LIQUOR.

Hawaii · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did HI HB 108 pass?

No. HI HB 108 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-08): Carried over to 2026 Regular Session.

What is HI HB 108 about?

Allows direct shipment of beer and distilled spirits by certain licensees. Requires the liquor commissions to adopt rules. Effective 7/1/2050. (SD1)

Who sponsors HI HB 108?

MORIKAWA is the primary sponsor of HI HB 108.

Description

Allows direct shipment of beer and distilled spirits by certain licensees. Requires the liquor commissions to adopt rules. Effective 7/1/2050. (SD1)

Introduced
2025-01-16
Latest action
2025-12-08 — Carried over to 2026 Regular Session.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • MORIKAWAprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2025-12-08

    Carried over to 2026 Regular Session.

    carried-over

  2. 2025-03-28

    The committee on JDC deferred the measure.

    deferral

  3. 2025-03-25

    The committee(s) on JDC will hold a public decision making on 03-28-25 10:02AM; Conference Room 016 & Videoconference.

  4. 2025-03-21

    Reported from CPN/EIG (Stand. Com. Rep. No. 1342) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.

  5. 2025-03-21

    Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.

    passage,reading-2,referral-committee

  6. 2025-03-20

    The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPN were as follows: 4 Aye(s): Senator(s) Keohokalole, McKelvey, Richards; Aye(s) with reservations: Senator(s) Fukunaga ; 1 No(es): Senator(s) Awa; and 0 Excused: none.

    committee-passage-favorable

  7. 2025-03-20

    The committee(s) on EIG recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in EIG were as follows: 4 Aye(s): Senator(s) Wakai, Chang, DeCoite, Richards; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.

    committee-passage-favorable

  8. 2025-03-14

    The committee(s) on CPN/EIG has scheduled a public hearing on 03-20-25 9:30AM; Conference Room 229 & Videoconference.

  9. 2025-03-04

    Received from House (Hse. Com. No. 82).

    introduction,receipt

  10. 2025-03-04

    Passed First Reading.

    reading-1

  11. 2025-03-04

    Referred to CPN/EIG, JDC.

    referral-committee

  12. 2025-02-28

    Reported from FIN (Stand. Com. Rep. No. 945), recommending passage on Third Reading.

  13. 2025-02-28

    Passed Third Reading with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Pierick, Templo, Ward excused (4). Transmitted to Senate.

    passage

  14. 2025-02-21

    The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 13 Ayes: Representative(s) Yamashita, Takenouchi, Grandinetti, Holt, Hussey, Keohokapu-Lee Loy, Kitagawa, Kusch, Lamosao, Miyake, Morikawa, Templo, Reyes Oda; Ayes with reservations: none; Noes: none; and 3 Excused: Representative(s) Lee, M., Alcos, Ward.

    committee-passage-favorable

  15. 2025-02-19

    Bill scheduled to be heard by FIN on Friday, 02-21-25 12:00PM in House conference room 308 VIA VIDEOCONFERENCE.

  16. 2025-02-14

    Reported from JHA (Stand. Com. Rep. No. 741) as amended in HD 2, recommending referral to FIN.

  17. 2025-02-14

    Report adopted; referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Matayoshi, Poepoe, Ward excused (4).

    passage,referral-committee

  18. 2025-02-13

    The committee on JHA recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 10 Ayes: Representative(s) Tarnas, Poepoe, Belatti, Hashem, Kahaloa, Perruso, Takayama, Todd, Garcia, Shimizu; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Cochran.

    committee-passage-favorable

  19. 2025-02-10

    Bill scheduled to be heard by JHA on Thursday, 02-13-25 2:00PM in House conference room 325 VIA VIDEOCONFERENCE.

  20. 2025-02-05

    Reported from CPC (Stand. Com. Rep. No. 160) as amended in HD 1, recommending passage on Second Reading and referral to JHA.

  21. 2025-02-05

    Passed Second Reading as amended in HD 1 and referred to the committee(s) on JHA with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Ward excused (2).

    reading-2,referral-committee

  22. 2025-01-30

    The committee on CPC recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 10 Ayes: Representative(s) Matayoshi, Chun, Ilagan, Ichiyama, Iwamoto, Kong, Lowen, Marten, Tam, Pierick; Ayes with reservations: none; Noes: none; and Excused: none.

    committee-passage-favorable

  23. 2025-01-29

    The committee(s) on CPC recommend(s) that the measure be deferred until 01-30-25.

    deferral

  24. 2025-01-29

    Bill scheduled for decision making on Thursday, 01-30-25 2:00PM in conference room 329 VIA VIDEOCONFERENCE.

  25. 2025-01-27

    Bill scheduled to be heard by CPC on Wednesday, 01-29-25 2:00PM in House conference room 329 VIA VIDEOCONFERENCE.

  26. 2025-01-21

    Referred to CPC, JHA, FIN, referral sheet 1

    referral-committee

  27. 2025-01-16

    Introduced and Pass First Reading.

    introduction,reading-1

  28. 2025-01-13

    Prefiled.

Versions

Documents

Votes

  • The committee on CPC recommend that the measure be PASSED, WITH AMENDMENTS.

    2025-01-30 · pass · 10-0

    Member-level votes (10)
    • Matayoshi: yes
    • Chun: yes
    • Ilagan: yes
    • Ichiyama: yes
    • Iwamoto: yes
    • Kong: yes
    • Lowen: yes
    • Marten: yes
    • Tam: yes
    • Pierick: yes
  • The committee on JHA recommend that the measure be PASSED, WITH AMENDMENTS.

    2025-02-13 · pass · 10-0

    Member-level votes (11)
    • Tarnas: yes
    • Poepoe: yes
    • Belatti: yes
    • Hashem: yes
    • Kahaloa: yes
    • Perruso: yes
    • Takayama: yes
    • Todd: yes
    • Garcia: yes
    • Shimizu: yes
    • Cochran: not voting
  • The committee on FIN recommend that the measure be PASSED, UNAMENDED.

    2025-02-21 · pass · 13-0

    Member-level votes (17)
    • Yamashita: yes
    • Takenouchi: yes
    • Grandinetti: yes
    • Holt: yes
    • Hussey: yes
    • Keohokapu-Lee Loy: yes
    • Kitagawa: yes
    • Kusch: yes
    • Lamosao: yes
    • Miyake: yes
    • Morikawa: yes
    • Templo: yes
    • Reyes Oda: yes
    • Lee: not voting
    • M: not voting
    • Alcos: not voting
    • Ward: not voting
  • The committee(s) on EIG recommend(s) that the measure be PASSED, WITH AMENDMENTS.

    2025-03-20 · pass · 4-0

    Member-level votes (5)
    • Wakai: yes
    • Chang: yes
    • DeCoite: yes
    • Richards: yes
    • Fevella: not voting
  • The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS.

    2025-03-20 · pass · 4-1

    Member-level votes (5)
    • Keohokalole: yes
    • McKelvey: yes
    • Richards: yes
    • Fukunaga: yes
    • Awa: no

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=HB 108. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.